Smartphone-attached stethoscope targets Third World; BD Diagnostics gets clearance for MRSA test;

@FierceMedDev: Luminex snaps up diagnostics firm GenturaDx for $50M in cash. Item | Follow @FierceMedDev

 @MarkHFierce: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @MarkHFierce

 @DamianFierce: Stryker is recalling two all-metal hip implants after reports of corrosion and failure. Story | Follow @DamianFierce

> Australian scientists have designed a cheap-to-manufacture stethoscope that can be attached to a smartphone, hoping to improve access to medical care in the Third World. News

> Becton, Dickinson's diagnostics unit scored 510(k) clearance for a molecular test that identifies methicillin-resistant staphylococcus aureus (MRSA), an infectious disease commonly spread in hospitals. Release

> Ireland's NUI Galway is looking to mimic Stanford's Biodesign fellowship, bringing together academics to take conceptual devices from the lab to the marketplace. Article

> Devicemaker Restoration Robotics got a CE mark for the Artas system, a hair loss-treating device that harvests follicles directly from the scalp in a minimally invasive procedure. More

> Ventus Medical has launched Theravent, a snore-therapy device that received FDA clearance in June. Report

Biotech News

 @FierceBiotech: Australian ‪cancer‬ ‪biotech‬ spin-out Alchemia pitches $60M ‪IPO‬ stateside. More | Follow @FierceBiotech

 @JohnCFierce: Israel's RDD Pharma raised a bit more than $7M from Orbimed to develop drugs delivered up the anal canal. More | Follow @JohnCFierce

 @RyanMFierce: Biotech‬ Genkyotex nails down $26M to fund drug for diabetic kidney disease. More | Follow @RyanMFierce

> Rival sources tangle over claim that Celgene is mulling 'horrid' HGS bid. Article

> Experimental vaccine knocks the weight off flabby mice. More

> Dissidents trigger big shake up at QLT after board coup. News

Pharma News

 @FiercePharma: ‪Merck‬ KGaA says it'll stop investing in R&D in Portugal if drug bills don't get paid. More | Follow @FiercePharma

> Lilly could net $1.5B-plus from Cymbalta extension. Story

> Med students protest as Massachusetts relaxes pharma gift ban. Article

> Is it or isn't it? Celgene said to mull bid for HGS, or not. More

> Forest urges investors to reject Icahn's board nominees. News

Biotech IT News

> Mount Sinai Medical Center, Cloudera embrace Big Data in genomics. Story

> Voice software offers potential tool for clinical trials. Article

> ERT scoops up Invivodata for ePRO clinical trials tech. More

> Mytrus aligns leadership for at-home clinical trials biz. News

Suggested Articles

The agency also gave the company’s diagnostic, run on the high-throughput Panther Fusion laboratory platform, a green light for pooled testing.

Smith & Nephew has signed up to acquire Integra LifeSciences’ orthopedics business focused on the growing upper and lower extremity markets.

The company describes the continuous glucose monitor as the world’s smallest and thinnest diabetes sensor, with a disc about the size of two pennies.